Abbonarsi

Associations between atrial fibrillation and early outcomes of patients with heart failure and reduced or preserved ejection fraction - 26/02/14

Doi : 10.1016/j.ahj.2013.12.001 
Zubin J. Eapen, MD, MHS a, b, , Melissa A. Greiner, MS a, Gregg C. Fonarow, MD c, Zhong Yuan, MD, PhD d, Roger M. Mills, MD d, Adrian F. Hernandez, MD, MHS a, b, Lesley H. Curtis, PhD a, b
a Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC 
b Department of Medicine, Duke University School of Medicine, Durham, NC 
c Ahmanson-UCLA Cardiomyopathy Center, University of California, Los Angeles, Los Angeles, CA 
d Janssen Research & Development, LLC, Raritan, NJ 

Reprint requests: Zubin J. Eapen, MD, MHS, Duke Clinical Research Institute, PO Box 17969, Durham, NC 27715.

Riassunto

Background

The relative impact of atrial fibrillation on early outcomes of patients with heart failure with reduced or preserved ejection fraction (EF) is unknown.

Methods

We conducted a retrospective cohort study of clinical registry data linked to Medicare claims for patients with heart failure with reduced or preserved EF stratified by presence of atrial fibrillation at admission. Outcomes of interest were all-cause mortality and readmission at 30days. We used Kaplan-Meier methods to estimate mortality and calculated cumulative incidence estimates of readmission. We used Cox proportional hazards models to examine associations between atrial fibrillation and 30-day outcomes.

Results

Among 66,357 patients admitted to 283 hospitals between January 2001 and March 2006, 46% had atrial fibrillation (44% of patients with reduced EF and 48% of patients with preserved EF). After adjustment for other patient characteristics, atrial fibrillation was associated with a modestly higher risk of 30-day mortality (HR, 1.08; 95% CI, 1.03-1.14) and readmission (HR, 1.06; 95% CI, 1.02-1.11). In subgroup analyses, atrial fibrillation was associated with a higher risk of 30-day mortality (HR, 1.16; 95% CI, 1.08-1.25) among patients with preserved EF but not among patients with reduced EF. The association of atrial fibrillation with readmission did not differ by heart failure type (P=.37 for the interaction).

Conclusions

Atrial fibrillation was associated with higher 30-day mortality among patients with heart failure with preserved EF but not reduced EF. The association of atrial fibrillation with 30-day readmission was modest and did not differ by heart failure type.

Il testo completo di questo articolo è disponibile in PDF.

Mappa


 Jalal K. Ghali, MD, served as guest editor for this article.


© 2014  Mosby, Inc. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 167 - N° 3

P. 369 - Marzo 2014 Ritorno al numero
Articolo precedente Articolo precedente
  • Changing prevalence, profile, and outcomes of patients with HIV undergoing cardiac surgery in the United States
  • Antonio Polanco, Shinobu Itagaki, Yuting Chiang, Joanna Chikwe
| Articolo seguente Articolo seguente
  • Age and sex differences in inhospital complication rates and mortality after percutaneous coronary intervention procedures: Evidence from the NCDR®
  • Judith H. Lichtman, Yongfei Wang, Sara B. Jones, Erica C. Leifheit-Limson, Leslee J. Shaw, Viola Vaccarino, John S. Rumsfeld, Harlan M. Krumholz, Jeptha P. Curtis

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2025 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.